News/ US FDA rejects Sunovion’s nebulised COPD drug Richard Staines COPD, Mylan, respiratory, Sunovio, Theravance 0 Comment The US regulator has rejected Sunovion’s nebulised therapy for chronic obstructive pulmonary disease (COPD), leaving the company struggling Share X FDA rejects Sunovion’s nebulised COPD drug https://pharmaphorum.com/news/fda-rejects-sunovions-nebulised-copd-drug/
